Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Based on the latest financial reports, Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥543.69K ≈ $79.56K USD) by net assets (CN¥1.15 Billion ≈ $168.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688266 company net worth for the company's overall valuation and market capitalisation.

Suzhou Zelgen Biopharmaceuticals Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Suzhou Zelgen Biopharmaceuticals Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Suzhou Zelgen Biopharmaceuticals Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Suzhou Zelgen Biopharmaceuticals Co Ltd ranked by their cash flow conversion efficiency. See debt repayment capacity of Suzhou Zelgen Biopharmaceuticals Co Ltd to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Golar LNG Limited NASDAQ:GLNG	0.048x
Tamarack Valley Energy Ltd TO:TVE	0.124x
China Nuclear Engineering Co SHG:601611	-0.037x
Kiwoom KO:039490	0.143x
GEM CO. LTD SP.GDR/10 A F:3730	N/A
Oceaneering International Inc NYSE:OII	0.047x
Insight Enterprises Inc NASDAQ:NSIT	0.013x
Shenzhen Suntak Circuit Technology Co Ltd SHE:002815	-0.011x

Annual Cash Flow Conversion Efficiency for Suzhou Zelgen Biopharmaceuticals Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Suzhou Zelgen Biopharmaceuticals Co Ltd from 2016 to 2024. View Suzhou Zelgen Biopharmaceuticals Co Ltd (688266) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.25 Billion ≈ $183.29 Million	CN¥38.20 Million ≈ $5.59 Million	0.031x	+122.77%
2023-12-31	CN¥1.64 Billion ≈ $240.69 Million	CN¥-220.31 Million ≈ $-32.24 Million	-0.134x	+71.52%
2022-12-31	CN¥787.49 Million ≈ $115.23 Million	CN¥-370.34 Million ≈ $-54.19 Million	-0.470x	-29.62%
2021-12-31	CN¥1.25 Billion ≈ $183.37 Million	CN¥-454.62 Million ≈ $-66.53 Million	-0.363x	-78.48%
2020-12-31	CN¥1.69 Billion ≈ $247.53 Million	CN¥-343.86 Million ≈ $-50.32 Million	-0.203x	+91.69%
2019-12-31	CN¥73.75 Million ≈ $10.79 Million	CN¥-180.43 Million ≈ $-26.40 Million	-2.446x	-512.81%
2018-12-31	CN¥281.64 Million ≈ $41.21 Million	CN¥-112.44 Million ≈ $-16.45 Million	-0.399x	+73.07%
2017-12-31	CN¥73.02 Million ≈ $10.69 Million	CN¥-108.25 Million ≈ $-15.84 Million	-1.482x	-186.02%
2016-12-31	CN¥109.44 Million ≈ $16.01 Million	CN¥-56.72 Million ≈ $-8.30 Million	-0.518x	--

About Suzhou Zelgen Biopharmaceuticals Co Ltd

SHG:688266 China Biotechnology

Market Cap

$4.59 Billion

CN¥31.39 Billion CNY

Market Cap Rank

#3803 Global

#548 in China

Share Price

CN¥118.58

Change (1 day)

-0.66%

52-Week Range

CN¥75.75 - CN¥147.40

All Time High

CN¥147.40